Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins.
Lifson JD, Rossio JL, Piatak M Jr, Bess J Jr, Chertova E, Schneider DK, Coalter VJ, Poore B, Kiser RF, Imming RJ, Scarzello AJ, Henderson LE, Alvord WG, Hirsch VM, Benveniste RE, Arthur LO. Lifson JD, et al. Among authors: rossio jl. AIDS Res Hum Retroviruses. 2004 Jul;20(7):772-87. doi: 10.1089/0889222041524661. AIDS Res Hum Retroviruses. 2004. PMID: 15307924
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.
Lifson JD, Rossio JL, Arnaout R, Li L, Parks TL, Schneider DK, Kiser RF, Coalter VJ, Walsh G, Imming RJ, Fisher B, Flynn BM, Bischofberger N, Piatak M Jr, Hirsch VM, Nowak MA, Wodarz D. Lifson JD, et al. Among authors: rossio jl. J Virol. 2000 Mar;74(6):2584-93. doi: 10.1128/jvi.74.6.2584-2593.2000. J Virol. 2000. PMID: 10684272 Free PMC article.
Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.
Gorelick RJ, Benveniste RE, Lifson JD, Yovandich JL, Morton WR, Kuller L, Flynn BM, Fisher BA, Rossio JL, Piatak M Jr, Bess JW Jr, Henderson LE, Arthur LO. Gorelick RJ, et al. Among authors: rossio jl. J Virol. 2000 Dec;74(24):11935-49. doi: 10.1128/jvi.74.24.11935-11949.2000. J Virol. 2000. PMID: 11090194 Free PMC article.
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.
Lifson JD, Rossio JL, Piatak M Jr, Parks T, Li L, Kiser R, Coalter V, Fisher B, Flynn BM, Czajak S, Hirsch VM, Reimann KA, Schmitz JE, Ghrayeb J, Bischofberger N, Nowak MA, Desrosiers RC, Wodarz D. Lifson JD, et al. Among authors: rossio jl. J Virol. 2001 Nov;75(21):10187-99. doi: 10.1128/JVI.75.21.10187-10199.2001. J Virol. 2001. PMID: 11581387 Free PMC article.
Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge.
Lifson JD, Piatak M Jr, Cline AN, Rossio JL, Purcell J, Pandrea I, Bischofberger N, Blanchard J, Veazey RS. Lifson JD, et al. Among authors: rossio jl. J Med Primatol. 2003 Aug;32(4-5):201-10. doi: 10.1034/j.1600-0684.2003.00026.x. J Med Primatol. 2003. PMID: 14498980
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
Willey RL, Byrum R, Piatak M, Kim YB, Cho MW, Rossio JL Jr, Bess J Jr, Igarashi T, Endo Y, Arthur LO, Lifson JD, Martin MA. Willey RL, et al. Among authors: rossio jl jr. J Virol. 2003 Jan;77(2):1163-74. doi: 10.1128/jvi.77.2.1163-1174.2003. J Virol. 2003. PMID: 12502833 Free PMC article.
52 results